Identification of mitophagy-related genes with potential clinical utility in myocardial infarction at transcriptional level
Source check: Source checked. Not independent scientific confirmation.
Finding: Feature selection on two GEO datasets identified ATG5, TOMM20 and MFN2 as genes that differed transcriptionally between myocardial-infarction and stable-coronary-disease samples. Logistic-regression AUCs were 0.914 internally and 0.930 in an external GEO dataset; this is retrospective expression-based classification, not prospective diagnosis.
Technology: SVM/RF/LASSO feature selection and logistic regression identify a three-gene myocardial-infarction signature.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- SVM/RF/LASSO feature selection and logistic regression identify a three-gene myocardial-infarction signature.
- Test and result
- ATG5, TOMM20 and MFN2 expression distinguishes MI from stable coronary disease in the analyzed datasets.
- Limitation / still unknown
- The check used existing GEO expression datasets; clinical prospective performance was not tested.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC10250750/ · https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2023.1166324/full · https://pubmed.ncbi.nlm.nih.gov/37304955/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.